We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-1.02%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
-$388M
(-3.6%)
Cap. Flow
-$87.6M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
14.73%
Holding
713
New
186
Increased
183
Reduced
156
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$120M |
| 2 |
Chord Energy
CHRD
|
+$106M |
| 3 |
Electronic Arts
EA
|
+$96.9M |
| 4 |
Quest Diagnostics
DGX
|
+$89.2M |
| 5 |
Sensata Technologies
ST
|
+$76.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$138M |
| 2 |
Avnet
AVT
|
+$130M |
| 3 |
ERF
Enerplus Corporation
ERF
|
+$110M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$73.5M |
| 5 |
Honeywell
HON
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.43% |
| 2 | Technology | 19.78% |
| 3 | Energy | 7.84% |
| 4 | Industrials | 7.21% |
| 5 | Financials | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNAM
126
DELISTED
Avidity Biosciences
RNAM
| $26.4M | 0.25% |
645,658
+59,320
| +10% | +$1.7M |
|
|
WBTN
127
WEBTOON Entertainment Inc
WBTN
$1.23B
| $26M | 0.25% |
+1,139,200
| New | +$26.1M |
|
|
NVEI
128
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $25.9M | 0.25% |
+800,000
| New | +$25.8M |
|
129
Alkermes
ALKS
$8.22B
| $25.8M | 0.25% |
1,071,071
+1,231
| +0.1% | +$30.2K |
|
130
Uber
UBER
$143B
| $25.6M | 0.24% |
+352,732
| New | +$24.5M |
|
131
Axsome Therapeutics
AXSM
$11.2B
| $25.6M | 0.24% |
318,011
-42,117
| -12% | -$3.12M |
|
|
SEM
132
DELISTED
Select Medical
SEM
| $25.4M | 0.24% |
1,345,325
+728,508
| +118% | +$12.4M |
|
133
Textron
TXT
$14.7B
| $25.4M | 0.24% |
+295,691
| New | +$26.3M |
|
134
Check Point Software Technologies
CHKP
$13B
| $25.3M | 0.24% |
153,230
+95,219
| +164% | +$14.8M |
|
135
TG Therapeutics
TGTX
$7.96B
| $25.3M | 0.24% |
1,419,534
+14,937
| +1% | +$238K |
|
136
Starbucks
SBUX
$120B
| $25.2M | 0.24% |
323,296
+104,886
| +48% | +$8.54M |
|
137
Edwards Lifesciences
EW
$49.6B
| $24.6M | 0.23% |
266,078
-215,848
| -45% | -$19.1M |
|
138
Icon
ICLR
$12.6B
| $24.4M | 0.23% |
77,993
-75,969
| -49% | -$23.8M |
|
139
argenx
ARGX
$53.4B
| $24.4M | 0.23% |
+56,771
| New | +$21.7M |
|
140
BridgeBio Pharma
BBIO
$15.7B
| $24.1M | 0.23% |
949,570
+248,821
| +36% | +$6.8M |
|
141
Kenvue
KVUE
$36.9B
| $23.9M | 0.23% |
+1,312,745
| New | +$25.4M |
|
142
HealthEquity
HQY
$8.41B
| $23.7M | 0.23% |
+275,196
| New | +$22.2M |
|
|
HES
143
DELISTED
Hess
HES
| $23.6M | 0.23% |
160,071
-240,001
| -60% | -$36.8M |
|
|
MASI
144
DELISTED
Masimo
MASI
| $23.4M | 0.22% |
185,990
+132,844
| +250% | +$17.5M |
|
145
Ball Corp
BALL
$17.3B
| $23.4M | 0.22% |
+389,999
| New | +$26.1M |
|
146
International Flavors & Fragrances
IFF
$20.2B
| $23.2M | 0.22% |
243,692
+155,007
| +175% | +$14.2M |
|
147
Brown & Brown
BRO
$23.6B
| $23.2M | 0.22% |
+259,029
| New | +$22.5M |
|
148
Dynatrace
DT
$12.9B
| $23.1M | 0.22% |
515,300
+101,669
| +25% | +$4.68M |
|
|
HCP
149
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $22.9M | 0.22% |
+680,000
| New | +$21.1M |
|
150
Expedia Group
EXPE
$35.4B
| $22.5M | 0.21% |
178,721
-368,413
| -67% | -$45.4M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Woodline Partners held 713 positions worth $10.5B, down 3.6% from $10.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners's Q2 2024 filing shows 186 new, 183 increased, 156 reduced and 168 closed positions. Its largest new stake was Marsh: 585,204 shares worth $123M. The largest sale was Analog Devices, an estimated $138M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Technology and Energy.
- Woodline Partners's largest Q2 2024 buy was Marsh: 585,204 shares worth $123M.
- Woodline Partners added most to Chord Energy in Q2 2024, an estimated $106M increase.
- Woodline Partners's biggest Q2 2024 reduction was Avnet, cutting an estimated $130M.
- Woodline Partners fully exited Analog Devices in Q2 2024, selling an estimated $138M.
- Woodline Partners's ten largest holdings make up 15% of its $10.5B portfolio in Q2 2024.
- Woodline Partners opened 186 new positions and closed 168 in Q2 2024.
- Woodline Partners's portfolio value fell 3.6% quarter-over-quarter to $10.5B.
Based on Woodline Partners's 13F filing for Q2 2024, filed 14 Aug 2024.